Skip to main content
. Author manuscript; available in PMC: 2014 Feb 18.
Published in final edited form as: Bone. 2013 Aug 29;57(2):509–516. doi: 10.1016/j.bone.2013.08.022

Table 3.

Number of hips with THA or survived at the last follow-up for each Ficat stage.

Ficat stage at onset of treatment Survival (number; %) THA (number; %)
I (n = 16) 15 (93.75%) 1 (6.25%)
II (n = 52) 50 (96.16%) 2 (3.84%)
III (n = 10) 7 (70%) 3 (30%)
Total (n = 78) 72 (92.31%) 6 (7.69%)